BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20538694)

  • 21. Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding.
    Dinia L; Rubiera M; Ribo M; Maisterra O; Ortega G; del Sette M; Alvarez-Sabin J; Molina CA
    Neurology; 2009 Sep; 73(10):775-80. PubMed ID: 19738172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
    Sun P; Esteban G; Inokuchi T; Marco-Contelles J; Weksler BB; Romero IA; Couraud PO; Unzeta M; Solé M
    Br J Pharmacol; 2015 Nov; 172(22):5390-402. PubMed ID: 26362823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
    Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
    Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
    Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
    Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
    Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
    Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients.
    Koc-Zorawska E; Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2012; 36(1):242-7. PubMed ID: 23154672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SSAO inhibitors suppress hepatocellular tumor growth in mice.
    Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
    Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular adhesion protein-1 in human ischaemic stroke.
    Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
    Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.
    Jia L; Chopp M; Zhang L; Lu M; Zhang Z
    Stroke; 2010 Sep; 41(9):2071-6. PubMed ID: 20671252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects.
    Li HY; Lin MS; Wei JN; Hung CS; Chiang FT; Lin CH; Hsu HC; Su CY; Wu MY; Smith DJ; Vainio J; Chen MF; Chuang LM
    Clin Chim Acta; 2009 May; 403(1-2):97-101. PubMed ID: 19361461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
    Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
    Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.